Major Disease Coverage In China Presents An Opening For Commercial Insurers
This article was originally published in PharmAsia News
Executive Summary
New government guidelines for major disease coverage will leverage commercial insurers, and drive patient volume and demand for pharmaceuticals, analysts say.